Form 6-K China Nepstar Chain Drug For: Aug 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
China Nepstar Chain Drugstore (NPD) Reports Q2 Loss of RMB0.16/Share
August 28, 2014 6:24 AM EDTChina Nepstar Chain Drugstore (NYSE: NPD) reported Q2 EPS of (RMB0.16), versus (RMB0.04) reported last year. Revenue for the quarter came in at RMB686.6 million, versus RMB538.8 million reported last year.
For earnings history and earnings-related data on China Nepstar Chain Drugstore (NPD) click here.
... More